Lamotrigine in patients with epilepsy and comorbid depressive symptoms

Epilepsy and Behavior

Volumn 10, Issue 1, 2007, Pages 155-162

  Fakhoury, Toufic A ^a   Barry, John J ^b   Mitchell Miller, J ^c   Hammer, Anne E ^c   Vuong, Alain ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Depression; Epilepsy; Health outcomes; Lamotrigine; Psychiatric disorders

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADJUVANT THERAPY; ADULT; AGED; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; BALANCE DISORDER; BLURRED VISION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIPLOPIA; DISEASE SEVERITY; DIZZINESS; DRUG ACTIVITY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; FATIGUE; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MYDRIASIS; NAUSEA; NEUROFIBROMA; OPEN STUDY; PARESTHESIA; SELF REPORT; SIDE EFFECT; SOMNOLENCE; TENSION; UNSTEADINESS; VOMITING; WEAKNESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DEPRESSION; DRUG EVALUATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; TREATMENT OUTCOME; TRIAZINES;

EID: 33846362549     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.11.003     Document Type: Article

References (43)

1. Hermann B., Seidenberg M., and Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 41 (2000) S31-S41
2. Kanner A.M., and Nieto J.C. Depressive disorders in epilepsy. Neurology 53 5, Suppl. 2 (1999) S26-S32
3. Gilliam F. The impact of epilepsy on subjective health status. Curr Neurol Neurosci Rep 3 (2003) 357-362
4. Kanner A.M., and Palac C. Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav 1 (2000) 37-51
5. Wiegartz P., Seidenberg M., Woodard A., Gidal B., and Hermann B. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 53 Suppl. 2 (1999) S3-S8
6. Lambert M.V., and Bird J.M. The assessment and management of adult patients with epilepsy: the role of general practitioners and specialist services. Seizure 10 (2001) 341-346
7. Cramer J.A., Hammer A.E., and Kustra R.P. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy Behav 5 (2004) 702-707
8. Gilliam F., and Kanner A.M. Treatment of depressive disorders in epilepsy patients. Epilepsy Behav 3 (2002) 2-9
9. O'Donoghue M., Goodridge D., Redhead K., Sander J., and Duncan J. Assessing the psychosocial consequences of epilepsy: a community based study. Br J Gen Pract 49 (1999) 211-214
10. Jones J.E., Hermann B., Woodard J.L., et al. Screening for major depression in epilepsy using common self-report depression inventories. Epilepsia 46 (2005) 731-735
11. Goodwin G.M., Bowden C.L., Calabrese J.R., Grunze H., Kasper S., and White R. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance treatment in bipolar I disorder. J Clin Psychiatry 65 (2004) 432-441
12. Smith D., Chadwick D., Baker G., et al. Seizure severity and quality of life. Epilepsia 34 Suppl. 5 (1993) S31-S35
13. Edwards K.R., Sackellares J.C., and Vuong A. Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 2 (2001) 28-36
14. Ghaemi S.N., and Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers. Harvard Rev Psychiatry 8 (2000) 1-7
15. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl. 20 (1998) 22-33 quiz 34-57
16. Radloff L.S. The CES-D Scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1 (1977) 385-401
17. Beck A.T., Steer R.A., and Brown G.K. Beck Depression Inventory manual. 2nd ed. (1996), Psychological Corp, San Antonio, TX
18. Mason B.J., Kocsis J.H., Leon A.C., et al. Assessment of symptoms and change in dysthymic disorder. In: Kocsis J.H., and Klein D.N. (Eds). Diagnosis and treatment of chronic depression (1995), Guilford Press, New York 73-88
19. Lorr M., McNair D.M., and Droppleman L.F. Manual: Profile of Mood States (1971), Educational and Industrial Testing Service, San Diego, CA
20. Myers J.K., and Weismann M.M. Use of self-report symptom scale to detect depression in community samples. Am J Psychiatry 137 (1980) 1081-1084
21. Schulberg H.C., Saul M., McClelland M., Ganguli M., Christy W., and Frank R. Assessing depression in primary medical and psychiatric practices. Arch Gen Psychiatry 42 (1985) 1164-1170
22. Nyenhuis D.L., Yamamoto C., Luchetta T., Terrien A., and Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55 (1999) 79-86
23. Altman D.G. Practical statistics for medical research (1991), Chapman & Hall, London p. 285-288
24. Ettinger A., Reed M., and Cramer J. Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology 63 (2004) 1008-1014
25. Ettinger A.B., Weisbrot D.M., Nolan E.E., et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 39 (1998) 595-599
26. Gilliam F., Carter J., and Vahle V. Tolerability of antiseizure medications: implications for health outcomes. Neurology 63 (2004) S9-S12
27. Bowden C.L., Calabrese J.R., Sachs G., et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60 (2003) 392-400
28. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., and Rudd G.D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 60 (1999) 79-88
29. Calabrese J.R., Suppes T., Bowden C.L., et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 61 (2000) 841-850
30. Calabrese J.R., Bowden C.L., Sachs G., et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64 (2003) 1013-1024
31. Normann C., Hummel B., Schärer L.O., et al. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. J Clin Psychiatry 63 (2002) 337-344
32. Rocha F.L., and Hara C. Lamotrigine augmentation in unipolar depression. Int Clin Psychopharmacol 18 (2003) 97-99
33. Gabriel A. Lamotrigine adjunctive treatment in resistant unipolar depression: an open, descriptive study. Depression Anxiety 23 (2006) 485-488
34. Gutierrez R.L., McKercher R.M., Galea J., et al. Lamotrigine augmentation strategy for patients with treatment-resistant depression. CNS Spectr 10 (2005) 800-805
35. Barbosa L., Berk M., and Vorster M. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J Clin Psychiatry 64 (2003) 403-407
36. Sackellares D.K., and Sackellares J.C. Improvement in depression associated with partial epilepsy in patients treated with lamotrigine. Epilepsy Behav 3 (2002) 510-516
37. Barry J.J. The recognition and management of mood disorders as a comorbidity of epilepsy. Epilepsia 44 Suppl. 4 (2003) 30-40
38. Kanner A.M., Kozak A.M., and Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 1 (2000) 100-105
39. Judd L.L., Akiskal H.S., Maser J.D., et al. A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50 (1998) 97-108
40. Dunner D.L., Hendricksen H.E., Bea C., et al. Dysthymic disorder: treatment with citalopram. Depression Anxiety 15 (2002) 18-22
41. Klein D.N., Schwarz J.E., Rose S., et al. Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study. Am J Psychiatry 157 (2000) 931-939
42. Griffiths J., Ravindran A.V., Merali Z., et al. Dysthymia: a review of pharmacological and behavioral factors. Mol Psychiatry 5 (2000) 242-261
43. Hellerstein D.J., Samstag L.W., Cantillon M., et al. Follow-up assessment of medication-treated dysthymia. Prog Neuropsychopharmacol Biol Psychiatry 20 (1996) 427-442